drugset / Trial / NCT02113020
A Phase I Clinical Pharmacology Study of TAK-233 in Healthy Subjects
RandomizedCrossoverQuadruple-blindBasic science
Summary
The objective of this clinical trial is to examine the clinical pharmacology properties of TAK-233 in healthy female subjects
Timeline
- Start
- 2014-02
- Primary completion
- 2014-09
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TAK-233 | Unknown | — | Oral |
Indications
No indication recorded.